MODULATION THERAPEUTICS, INC.

Basic Information

818 BAYVIEW DR
RUSKIN, FL, 33570-2805

http://modulationtherapeutics.com/default.html

Company Profile

Modulation Therapeutics Incorporated is a research and development pharmaceutical company.

Additional Details

Field Value
DUNS: 968675244
Hubzone Owned: N
Socially and Economically Disadvantaged: Y
Woman Owned: N
Number of Employees: 6


  1. Second generation MTI-101 analogs using a novel peptoid-peptide hybrid beta-hairp

    Amount: $225,000.00

    MTI-101 is a cyclic beta-hairpin peptide that binds CD44 with high affinity and kills multiple myeloma cell lines in vitro and blocks the growth of myeloma tumors in 2 different murine models. This in ...

    STTR Phase I 2014 Department of Health and Human Services
  2. A Virtually Supervised Web-Based Home Exercise Technology for Older Adults

    Amount: $288,301.00

    DESCRIPTION (provided by applicant): The majority of multiple myeloma (MM) patients will initially respond to standard chemotherapy. However, eventually relapse of the disease, associated with a multi ...

    SBIR Phase I 2013 Department of Health and Human Services
  3. Chemical Optimization Designed to Increase the in vivo Efficacy of HM-27 for the

    Amount: $156,202.00

    DESCRIPTION (provided by applicant): This application requests funds to aid in obtaining the necessary additional preclinical data needed for commercialization of a promising new and novel drug candid ...

    SBIR Phase I 2012 Department of Health and Human Services
  4. Targeting CD44 in the bone marrow microenvironment of MM

    Amount: $218,817.00

    DESCRIPTION (provided by applicant): The majority of multiple myeloma (MM) patients will initially respond to standard chemotherapy. However, eventually relapse of the disease, associated with a multi ...

    SBIR Phase I 2012 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government